SERUM X Trademark

Trademark Overview

On Monday, May 24, 2021, a trademark application was filed for SERUM X with the United States Patent and Trademark Office. The USPTO has given the SERUM X trademark a serial number of 90731117. The federal status of this trademark filing is REGISTERED as of Tuesday, May 14, 2024. This trademark is owned by AO Biologix, LLC. The SERUM X trademark is filed in the Pharmaceutical Products category with the following description:

Pain relief medication
serum x

General Information

Serial Number90731117
Word MarkSERUM X
Filing DateMonday, May 24, 2021
Status700 - REGISTERED
Status DateTuesday, May 14, 2024
Registration Number7388399
Registration DateTuesday, May 14, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 27, 2023

Trademark Statements

Goods and ServicesPain relief medication
NOT AVAILABLE"SERUM"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 18, 2023
Primary Code005
First Use Anywhere DateSaturday, April 30, 2022
First Use In Commerce DateSaturday, April 30, 2022

Trademark Owner History

Party NameAO Biologix, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressPleasant Grove, UT 84062
Party NameAO Biologix, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressPleasant Grove, UT 84062
Party NameAO Biologix, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressPleasant Grove, UT 84062

Trademark Events

Event DateEvent Description
Thursday, May 27, 2021NEW APPLICATION ENTERED
Thursday, August 19, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 3, 2022ASSIGNED TO EXAMINER
Friday, February 18, 2022NON-FINAL ACTION WRITTEN
Friday, February 18, 2022NON-FINAL ACTION E-MAILED
Friday, February 18, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 18, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 18, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 19, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 19, 2022FINAL REFUSAL WRITTEN
Wednesday, October 19, 2022FINAL REFUSAL E-MAILED
Wednesday, October 19, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, April 19, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, April 19, 2023EXPARTE APPEAL RECEIVED AT TTAB
Wednesday, April 19, 2023JURISDICTION RESTORED TO EXAMINING ATTORNEY
Wednesday, April 19, 2023EX PARTE APPEAL-INSTITUTED
Thursday, May 18, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 18, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 18, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 7, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 27, 2023PUBLISHED FOR OPPOSITION
Tuesday, June 27, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 22, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, February 22, 2024TEAS STATEMENT OF USE RECEIVED
Thursday, February 22, 2024USE AMENDMENT FILED
Thursday, March 14, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 14, 2024STATEMENT OF USE PROCESSING COMPLETE
Friday, April 5, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, April 6, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, May 14, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, May 14, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

serum medication relief pain